Literature DB >> 9795036

Spray-drying of solid lipid nanoparticles (SLN TM).

C Freitas1, R H Müllerä.   

Abstract

Aqueous dispersions of solid lipid nanoparticles (SLNTM) were converted by spray-drying into dry, reconstitutable powders which could be stored over a long period. After redispersion, the resulting granulates were still acceptable for i.v. administration with respect to the particle size distribution and toxicity. Therefore only physiologically-acceptable excipients such as carbohydrates and alcohols (ethanol and methanol) were added to the SLN dispersions before spraying. The particle size was influenced by the applied spraying parameters and by the chemical nature of the lipid phase, the type of carbohydrate and the spraying, and the redispersion medium. An identical size distribution before and after the spraying process, followed by subsequent redispersion was achieved by: reducing the temperature by spraying alcoholic dispersions, reducing the lipid concentration while increasing the sugar concentration, and by redispersion in a poloxamer 188 solution.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795036     DOI: 10.1016/s0939-6411(97)00172-0

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  31 in total

1.  Duloxetine HCl lipid nanoparticles: preparation, characterization, and dosage form design.

Authors:  Ketan Patel; Sameer Padhye; Mangal Nagarsenker
Journal:  AAPS PharmSciTech       Date:  2011-12-14       Impact factor: 3.246

2.  Structural characterization of Q10-loaded solid lipid nanoparticles by NMR spectroscopy.

Authors:  Sylvia A Wissing; Rainer H Müller; Lars Manthei; Christian Mayer
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

3.  Modified nanoprecipitation method for preparation of cytarabine-loaded PLGA nanoparticles.

Authors:  Khushwant S Yadav; Krutika K Sawant
Journal:  AAPS PharmSciTech       Date:  2010-09-15       Impact factor: 3.246

4.  Inhalable microparticles as carriers for pulmonary delivery of thymopentin-loaded solid lipid nanoparticles.

Authors:  Yan-Zhen Li; Xun Sun; Tao Gong; Jie Liu; Jiao Zuo; Zhi-Rong Zhang
Journal:  Pharm Res       Date:  2010-07-13       Impact factor: 4.200

5.  Evaluation of functional stability of quercetin as a raw material and in different topical formulations by its antilipoperoxidative activity.

Authors:  Rúbia Casagrande; Sandra R Georgetti; Waldiceu A Verri; José R Jabor; Antonio C Santos; Maria J V Fonseca
Journal:  AAPS PharmSciTech       Date:  2006-02-03       Impact factor: 3.246

6.  Tumoricidal effects of etoposide incorporated into solid lipid nanoparticles after intraperitoneal administration in Dalton's lymphoma bearing mice.

Authors:  Lakkireddy Harivardhan Reddy; Jawahar Singh Adhikari; Bilikere Srinirasa Rao Dwarakanath; Rakesh Kumar Sharma; Rayasa Ramachandra Murthy
Journal:  AAPS J       Date:  2006-04-14       Impact factor: 4.009

7.  Nanoparticles: Emerging carriers for drug delivery.

Authors:  Sagar R Mudshinge; Amol B Deore; Sachin Patil; Chetan M Bhalgat
Journal:  Saudi Pharm J       Date:  2011-04-21       Impact factor: 4.330

8.  Conversion of nanosuspensions into dry powders by spray drying: a case study.

Authors:  Mahesh V Chaubal; Carmen Popescu
Journal:  Pharm Res       Date:  2008-05-29       Impact factor: 4.200

Review 9.  Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives.

Authors:  Melike Uner; Gülgün Yener
Journal:  Int J Nanomedicine       Date:  2007

10.  Solid lipid nanoparticles: a modern formulation approach in drug delivery system.

Authors:  S Mukherjee; S Ray; R S Thakur
Journal:  Indian J Pharm Sci       Date:  2009-07       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.